COLUMN GROUP II, LP

SAN FRANCISCO, CA Venture Capital Fund How do I update this listing?

Column Group II is based out of San Francisco. Whalewisdom has at least 7 13D filings, 5 13G filings, and 7 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2014-09-16. The filing was for a pooled investment fund: venture capital fund The notice included securities offered of Equity,Pooled Investment Fund Interests

Create Alert
Current 13D/G Holdings
Stock Sector Shares Held Market Value Rank Source Source Date
RAPT Therapeutics, Inc. (RAPT) HEALTH CARE 3,156,230 110,909,922.20 1 13D 2021-09-10
ORIC Pharmaceuticals, Inc. (ORIC) HEALTH CARE 4,768,181 84,349,121.89 2 13G 2020-12-31
eFFECTOR Therapeutics Inc (EFTR) HEALTH CARE 4,309,329 73,172,406.42 3 13D 2021-08-25

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2014-09-16 D/A POOLED INVESTMENT FUND: VENTURE CAPITAL FUND Equity,Pooled Investment Fund Interests 306,000,000 306,000,000 0
2014-04-11 D POOLED INVESTMENT FUND: VENTURE CAPITAL FUND Equity,Pooled Investment Fund Interests 250,000,000 175,850,000 74,150,000
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
DAVID V. GOEDDEL, PH.D. subscription required
    EXECUTIVE OFFICER
LAURENCE LASKY, PH.D. subscription required
    EXECUTIVE OFFICER
PETER SVENNILSON subscription required
    EXECUTIVE OFFICER
TIM KUTZKEY, PH.D. subscription required
    EXECUTIVE OFFICER

Elevate your investments